ProMIS Neurosciences Obtains Receipt for Final Base Shelf Prospectus
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR...
Month: July 2021
Helius Medical Technologies, Inc. Appoints Antonella Favit-Van Pelt, M.D., Ph.D. as Chief Medical Officer
NEWTOWN, Pa., July 08, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech...
Nephros Announces Preliminary Results for Second Quarter of 2021
Anticipates Net Revenue of $2.2 Million, Greater Than 40% Year-Over-Year Increase;Submits HDF Product to FDA for 510(k) Clearance SOUTH ORANGE,...
FDA Approves Updated ADUHELM™ Prescribing Information to Emphasize Population Studied in Clinical Trials
ADUHELM should be initiated in patients with mild cognitive impairment due to Alzheimer’s disease or mild Alzheimer’s dementiaCAMBRIDGE, Mass. and...
Better Choice Announces Increased Insider Participation
NEW YORK, July 08, 2021 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE American: BTTR) (“Better Choice”), an animal health and...
Trevena Announces First Patient Enrolled in OLINVYK® Phase 3 Trial in China in Partnership with Jiangsu Nhwa Pharmaceutical
Nhwa is conducting and funding this study to support NDA regulatory filing in China Trevena expects to receive approval and...
Pluristem Brings ARDS Associated with COVID-19 Phase II Studies to Clinical Readout
The company will analyze data based on patients enrolled to date in COVID-19 Phase II studies in U.S., Europe and...
VBL Therapeutics Appoints Alison Finger and Michael Rice to its Board of Directors
TEL AVIV, Israel, July 08, 2021 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT) today announced the appointments of Alison Finger...
Autolus Therapeutics to Report Second Quarter 2021 Financial Results on August 5, 2021, and will Participate in the William Blair Biotech Focus Conference 2021 on July 14, 2021
LONDON, July 08, 2021 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell...
Ikena Oncology to Participate in Targeted Oncology Panel at the William Blair Biotech Focus Conference 2021
BOSTON, July 08, 2021 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA), a targeted oncology company focused on developing therapies...
Surface Oncology Appoints Denice Torres to Board of Directors
Brings 25 years of strategic leadership experience across healthcareCAMBRIDGE, Mass., July 08, 2021 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a...
Microbix Presenting Product Results to Industry
Two Abstracts Reporting on Cross-Platform Utility of Antigen & Serological QAPs™MISSISSAUGA, Ontario, July 08, 2021 (GLOBE NEWSWIRE) -- Microbix Biosystems...
Global WholeHealth Partners Corp (OTC:GWHP) Ships Its First Shipment of Over 20,000 Tests to Salud Previa of Tijuana, MX; Salud Previa Has Indicated That It Plans on Purchasing More Than 500,000 Tests Over the Next 12 Months
San Clemente, CA, July 08, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Global WholeHealth Partners Corp. (OTC: GWHP) offers one of...
Aclaris Therapeutics to Participate in the William Blair Biotech Focus Conference 2021
WAYNE, Pa., July 08, 2021 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing...
NMD Pharma Initiates ESTABLISH Study in Patients with Charcot-Marie-Tooth Disease
PRESS RELEASE NMD Pharma Initiates ESTABLISH Study in Patients with Charcot-Marie-Tooth Disease The international observational study will be conducted in...
AGTC to Host Virtual R&D Day on July 22, 2021
Widely Recognized Experts and AGTC Leadership Will Expand on Recent ACHM Phase 1/2 Clinical Trial Data and Discuss XLRP Milestones...
Evaxion Biotech Reports Data from Phase 1/2a Trials of EVX-01 and EVX-02
New clinical data demonstrates antitumor effect of EVX-01 in combination with anti-PD1 treatmentObjective Response Rate (ORR) of 67% with EVX-01...
Dante Labs commits to ending Rare Disease Odysseys globally through Stripe2be: a patient-centric whole genome based solution tailored for rare disease patients
Dante Labs Clinical Laboratory A DNA and RNA extraction room in Dante Labs Clinical Laboratory Stripe2be uses an unbiased approach...
Active Biotech’s partner NeoTX will host KOL webinar on overcoming check point Inhibitor resistance
Lund, July 8 2021 - Active Biotech (Nasdaq Stockholm: ACTI) today provided information that its partner in the naptumomab project,...
Chr. Hansen Holding A/S Interim Report Q3 2020/21
July 8, 2021 Company announcement no. 9 Third quarter in line with expectations and outlook for 2020/21 unchanged Q3 2020/21...